PharmaTher Develops 3D Printed Tablets for Targeted Colon Drug Delivery
PharmaTher Holdings is advancing a series of 3D printed peptide tablets aimed at treating gastrointe…
PharmaTher Holdings is advancing a series of 3D printed peptide tablets aimed at treating gastrointe…
PharmaTher Holdings is introducing a line of 3D printed peptide tablets designed for colon release, …
PharmaTher is establishing the M3DICINES National Network Program to create a network of U.S. locati…
MB Therapeutics, a French start-up, has received approval from the French National Agency for Medici…
MB Therapeutics has gained authorization from the French National Agency for the Safety of Medicines…